We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
-12.93%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$591B
AUM Growth
-$94.6B
Cap. Flow
+$3.09B
Cap. Flow %
0.52%
Top 10 Hldgs %
20.46%
Holding
2,656
New
75
Increased
1,551
Reduced
819
Closed
97

Top Sells

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$2.72B
2
BKNG icon
Booking.com
BKNG
+$2.61B
3
RHT
Red Hat Inc
RHT
+$1.62B
4
JPM icon
JPMorgan Chase
JPM
+$1.43B
5
STT icon
State Street
STT
+$1.29B

Sector Composition

Rank Sector Weight
1 Healthcare 18.46%
2 Technology 17.53%
3 Financials 14.18%
4 Consumer Discretionary 14.02%
5 Communication Services 9.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HTBK
701
DELISTED
Heritage Commerce
HTBK
$68.8M 0.01%
6,064,670
+13,024
+0.2% +$181K
TFC icon
702
Truist Financial
TFC
$64.7B
$68.7M 0.01%
1,586,603
+23,900
+2% +$1.15M
WEX icon
703
WEX
WEX
$6.78B
$68.5M 0.01%
489,279
+8,355
+2% +$1.38M
ECPG icon
704
Encore Capital Group
ECPG
$2.15B
$68.5M 0.01%
2,913,250
+1,066,212
+58% +$28.6M
ZBRA icon
705
Zebra Technologies
ZBRA
$18B
$68.2M 0.01%
428,019
-103,965
-20% -$17.3M
FRGI
706
DELISTED
Fiesta Restaurant Group, Inc.
FRGI
$68M 0.01%
4,384,155
-521,264
-11% -$11.4M
BR icon
707
Broadridge
BR
$19.6B
$67.9M 0.01%
704,944
+3,972
+0.6% +$430K
PRI icon
708
Primerica
PRI
$9.62B
$67.4M 0.01%
689,366
+7,683
+1% +$854K
ATHN
709
DELISTED
Athenahealth, Inc.
ATHN
$67.3M 0.01%
510,156
-851,043
-63% -$109M
WVE icon
710
Wave Life Sciences
WVE
$1.02B
$67.1M 0.01%
1,595,506
-98,386
-6% -$4.38M
WTFC icon
711
Wintrust Financial
WTFC
$11B
$66.8M 0.01%
1,004,289
-21,331
-2% -$1.62M
ATRC icon
712
AtriCure
ATRC
$2.21B
$66.7M 0.01%
2,180,333
-34,358
-2% -$1.07M
DXCM icon
713
DexCom
DXCM
$34.5B
$66.7M 0.01%
2,226,036
-15,779,120
-88% -$501M
PRAH
714
DELISTED
PRA Health Sciences, Inc.
PRAH
$66.5M 0.01%
723,610
+29,236
+4% +$2.96M
COKE icon
715
Coca-Cola Consolidated
COKE
$12.7B
$66.5M 0.01%
3,748,850
+19,990
+0.5% +$370K
TGI
716
DELISTED
Triumph Group
TGI
$66.2M 0.01%
5,753,357
+782,474
+16% +$13.6M
TYL icon
717
Tyler Technologies
TYL
$13.5B
$66.1M 0.01%
355,839
-2,970
-0.8% -$587K
SGI
718
Somnigroup International
SGI
$14B
$66.1M 0.01%
6,386,904
-1,302,476
-17% -$15.6M
AFL icon
719
Aflac
AFL
$60.7B
$66M 0.01%
1,447,711
+23,360
+2% +$1.04M
CTSH icon
720
Cognizant
CTSH
$26.7B
$66M 0.01%
1,038,982
+10,747
+1% +$748K
ALLO icon
721
Allogene Therapeutics
ALLO
$683M
$65.9M 0.01%
+2,511,998
New +$66.7M
KRNY icon
722
Kearny Financial
KRNY
$604M
$65.9M 0.01%
5,138,843
-50,954
-1% -$663K
MGRC icon
723
McGrath RentCorp
MGRC
$2.94B
$65.6M 0.01%
1,274,677
+6,214
+0.5% +$320K
AVX
724
DELISTED
AVX Corporation
AVX
$65.4M 0.01%
4,286,873
+1,328,134
+45% +$21.4M
MMS icon
725
Maximus
MMS
$2.94B
$65.3M 0.01%
1,003,022
-6,336
-0.6% -$417K

Similar funds

T. Rowe Price Associates's Q4 2018 Portfolio in Review

As of Q4 2018, T. Rowe Price Associates held 2,656 positions worth $591B, down 14% from $685B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

T. Rowe Price Associates's Q4 2018 filing shows 75 new, 1,551 increased, 819 reduced and 97 closed positions. Its largest new stake was StoneCo: 28,883,228 shares worth $519M. The largest sale was Tesla, an estimated $2.72B.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 18% a quarter earlier, followed by Technology and Financials.

  • T. Rowe Price Associates's largest Q4 2018 buy was StoneCo: 28,883,228 shares worth $519M.
  • T. Rowe Price Associates added most to Meta Platforms (Facebook) in Q4 2018, an estimated $2.16B increase.
  • T. Rowe Price Associates's biggest Q4 2018 reduction was Tesla, cutting an estimated $2.72B.
  • T. Rowe Price Associates fully exited Aetna Inc in Q4 2018, selling an estimated $600M.
  • T. Rowe Price Associates's ten largest holdings make up 20% of its $591B portfolio in Q4 2018.
  • T. Rowe Price Associates opened 75 new positions and closed 97 in Q4 2018.
  • T. Rowe Price Associates's portfolio value fell 14% quarter-over-quarter to $591B.

Based on T. Rowe Price Associates's 13F filing for Q4 2018, filed 14 Feb 2019.